Gastrointestinal symptoms related to the irritable bowel syndrome - A longitudinal population-based register study

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 4, 2016, Pages 420-426

  Heinsvig Poulsen, Chalotte ^a,b   Falgaard Eplov, Lene ^b   Hjorthøj, Carsten ^b   Eliasen, Marie ^a   Frost Ebstrup, Jeanette ^a   Skovbjerg, Sine ^a   Schröder, Andreas ^c   Jørgensen, Torben ^a,d,e  

^a Research Centre for Prevention and Health   (Denmark)

^b Mental Health Centre Copenhagen   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AALBORG UNIVERSITY   (Denmark)

Author keywords

Gastrointestinal diseases; irritable bowel syndrome; mortality

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; COHORT ANALYSIS; DIZZINESS; EDUCATIONAL STATUS; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LONGITUDINAL STUDY; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; COMPLICATION; GASTROINTESTINAL DISEASES; IRRITABLE BOWEL SYNDROME; REGISTER;

ABDOMINAL PAIN; ADULT; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGISTRIES;

EID: 84955194770     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1117652     Document Type: Article

References (38)

1. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949-958
2. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31-39
3. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71-80
4. Garcá Rodrguez LA, Ruigómez A, Wallander MA, et al. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 2000;35:306-311
5. Nørgaard M, Farkas DK, Pedersen L, et al. Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer. 2011;104:1202-1206
6. Canavan C, Card T, West J. The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study. PLoS One. 2014;9:e106478
7. Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res. 2008;64:573-582
8. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006;41:650-656
9. Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowel syndrome in Denmark. A populationbased survey in adults-50 years of age. Scand J Gastroenterol. 2013;48:523-529
10. Chang JY, Locke GR, McNally MA, et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010;105:822-832
11. Kay L, Jørgensen T, Lanng C. Irritable bowel syndrome: which definitions are consistent? J Intern Med. 1998; 244:489-494
12. Saito YA, Locke GR, Talley NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000;95:2816-2824
13. Mearin F, Badá X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001;36:1155-1161
14. Whitehead WE, Drossman DA. Validation of symptombased diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol. 2010;105:814-820; Quiz: 813, 821
15. Kay L, Jørgensen T. Redefining abdominal syndromes. Results of a population-based study. Scand J Gastroenterol. 1996;31:469-475
16. Kay L, Jørgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med. 1994;236:23-30
17. Lanng C, Mortensen D, Friis M, et al. Gastrointestinal dysfunction in a community sample of subjects with symptoms of irritable bowel syndrome. Digestion. 2003;67:14-19
18. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39:22-25
19. Jørgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol. 1987;126:912-921
20. Jørgensen T, Borch-Johnsen K, Thomsen TF, et al. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil. 2003;10: 377-386
21. Jensen KH, Jørgensen T. Incidence of gallstones in a Danish population. Gastroenterology. 1991;100:790-794
22. Jørgensen T, Jacobsen RK, Toft U, et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ. 2014;348:g3617
23. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30-33
24. Agréus L, Svärdsudd K, Nyrén O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671-680
25. Eplov LF, Petersen J, Jørgensen T, et al. The Mental Vulnerability Questionnaire: a psychometric evaluation. Scand J Psychol. 2010;51:548-554
26. Mearin F, Baró E, Roset M, et al. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol. 2004;99:113-121
27. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140-1156
28. Tang Y-R, Wang P, Yin R, et al. Five-year follow-up of 263 cases of functional bowel disorder. World J Gastroenterol. 2013;19:1466-1471
29. Porter CK, Cash BD, Pimentel M, et al. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol. 2012; 12:55
30. Hsiao C-W, Huang W-Y, Ke T-W, et al. Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study. Eur J Intern Med. 2014; 25:82-86
31. Begtrup LM, Engsbro AL, Kjeldsen J, et al. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11:956.e1-962.e1
32. Schrö der A, Fink P. Functional somatic syndromes and somatoform disorders in special psychosomatic units: organizational aspects and evidence-based treatment. Psychiatr Clin North Am. 2011;34:673-687
33. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381-396
34. Price DD, Zhou Q, Moshiree B, et al. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain. 2006;7:529-535
35. Lembo AJ, Zaman M, Krueger RF, et al. Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins. Am J Gastroenterol. 2009;104:686-694
36. Janssens KAM, Zijlema WL, Joustra ML, et al. Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines Cohort Study. Psychosom Med. 2015;77:449-457
37. Kendell RE. Clinical validity. Psychol Med. 1989;19:45-55
38. Drossman DA. Rome III: the new criteria. Chin J Dig Dis. 2006;7:181-185.